Symbyax Lawsuit

 

A brief guide to filing a Symbyax lawsuit

 

Used to treat bipolar disorder and depression, the prescription medication Symbyax has been the subject of some controversy regarding its safety. However, to date no significant Symbyax settlement payment has been recorded. The manufacturer has updated information regarding Symbyax side effects several times. These new warnings have not produced any notable Symbyax settlement.

 

This medication combines two different active ingredients, olanzapine and fluoxetine. While post-market studies specifically regarding Symbyax side effects have not yet been conducted, there is some evidence that olanzapine by itself poses some risks. Nearly 24,000 lawsuits regarding olanzapine in the form of the medication Zyprexa have been settled. This information could be taken into account when filing a Symbyax lawsuit.

 

Like any antidepressant, there is a risk of Symbyax side effects including suicidal impulses in patients 24 or younger. In 2007, the FDA mandated that a warning of such possibilities be included with all antidepressants. However, if any Symbyax settlement was sought as a result of this announcement, it has not been recorded. Since this warning has been on the product for five years now, you are unlikely to be able to pursue a Symbyax lawsuit on behalf of yourself or someone who killed themselves after 2007. The statute of limitations in your state for seeking a Symbyax settlement related to events prior to this time has probably expired.

 

In 2011, the FDA mandated a change in the warning information concerning Symbyax side effects on newborns. Use of antipsychotics throughout the third trimester of pregnancy was determined to pose an increased risk of birth defects. Notably, Symbyax side effects could include withdrawal symptoms in newborns.

 

Often a change in an FDA warning label compels many patients to file litigation such as a Symbyax lawsuit. Patients could pursue compensation for Symbyax side effects related primarily to medical expenses. The primary grounds for a Symbyax settlement would be that the manufacturer failed to adequately warn consumers before 2011 about the risks of taking the medication, which could also form a basis for punitive damages. Such a Symbyax lawsuit would be following the precedent of many previous suits seeking compensation on similar grounds.

 

There are several particularly notable Symbyax side effects that can form grounds for compensation. Withdrawal symptoms take the shape of unusual muscle movements, known as extrapyramidal signs. Women who gave birth to a child who demonstrated these symptoms would be entitled to seek a Symbyax settlement. Similarly, many heart conditions and spina bifida could also be grounds to pursue a Symbyax lawsuit.

 

If you are a woman who gave birth to a child with birth defects before the 2011 warning update, it is important to act quickly to pursue a Symbyax settlement. While in some states you will still be within the statute of limitations for a Symbyax lawsuit, it takes time to assemble a strong case. Documentation will be needed of these Symbyax side effects. For an attorney to pursue a strong Symbyax lawsuit, it will be helpful if multiple plaintiffs combine similar complaints into one legal action. In the absence of definitive studies focused specifically on this particular drug, this will make it easier to establish the validity of a claim for a Symbyax settlement.

Related Topics